Wednesday - July 1, 2026

Use of Sepiapterin and Metabolites Thereof to Treat Radiation Exposure

2026-06-30

ALEXANDRIA, Virginia, June 30 -- VIRGINIA COMMONWEALTH UNIVERSITY, Richmond, Virginia has been assigned a patent (No. US 12667569 B2, initially filed Aug. 5, 2020) developed by five inventors Eleonora Mezzaroma, Glen Allen, Virginia; Christopher Rabender, Chesterfield, Virginia; Ross Mikkelsen, Richmond, Virginia; Vasily Yakovlev, Richmond, Virginia; and Neil Smith, Cary, North Carolina, for "Use of sepiapterin and metabolites thereof to treat radiation exposure." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Use of Sepiapterin and Metabolites Thereof to Treat Radiation Exposure

Information Request Form

Copyright Targeted News Service 2026